Trade
Markets
Copy
Contests

News
24/7
Calendar

Q&A
Chats

Trending

SYMBOL

LAST

BID

ASK

HIGH

LOW

NET CHG.

%CHG.

SPREAD

SPX

S&P 500 Index

6886.69

6886.69

6886.69

6900.68

6824.70

+46.18

+ 0.68%

--

DJI

Dow Jones Industrial Average

48057.74

48057.74

48057.74

48197.30

47462.94

+497.46

+ 1.05%

--

IXIC

NASDAQ Composite Index

23654.15

23654.15

23654.15

23704.08

23435.17

+77.67

+ 0.33%

--

USDX

US Dollar Index

98.600

98.680

98.600

99.210

98.530

-0.580

-0.58%

--

EURUSD

Euro / US Dollar

1.16927

1.16934

1.16927

1.16994

1.16215

+0.00670

+ 0.58%

--

GBPUSD

Pound Sterling / US Dollar

1.33828

1.33839

1.33828

1.33884

1.32894

+0.00877

+ 0.66%

--

XAUUSD

Gold / US Dollar

4230.55

4230.99

4230.55

4238.54

4181.89

+23.38

+ 0.56%

--

WTI

Light Sweet Crude Oil

58.814

58.844

58.814

58.861

57.533

+0.659

+ 1.13%

--

All
Chatrooms
Groups
Friends

Connecting

.

.

.

Type here...

All
Russia-Ukraine Conflict
Middle East Flashpoint

Dj Quantum Si Inc Cl A, Inst Holders, 3Q 2025 (Qsi)

Reuters

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

Press Release: Quantum-Si Highlights Significant Development Advancements For Proteus(Tm) And Industry Leading Technology Pipeline At Investor & Analyst Day

Reuters

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

QSI: Proteus platform advances protein sequencing with scalable, cost-efficient architecture and strong early results

Quartr

Quantum-Si Incorporated Warrant

Proteus, a next-generation protein sequencing platform, is on track for a 2026 launch, offering major architectural advances for scalability and cost efficiency. Early data show performance exceeding current systems, with commercialization strategies and financial resources in place to support growth.

Based on Quantum-Si Incorporated [QSI] CG MedTech, Diagnostics and Digital Health & Services Forum Audio Transcript — Nov. 20 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

QSI: Proteus will launch in 2026, delivering scalable, high-output protein sequencing with robust financial backing

Quartr

Quantum-Si Incorporated Warrant

Proteus, a next-generation protein sequencing platform, is on track for a 2026 launch, offering major architectural advances, higher throughput, and lower consumable costs. The company is financially strong, with a flexible commercialization strategy and a focus on full proteome coverage using AI-driven R&D.

Based on Quantum-Si Incorporated [QSI] CG MedTech, Diagnostics and Digital Health & Services Forum Audio Transcript — Nov. 20 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

Press Release: Quantum-Si To Highlight Significant Proteus(Tm) Platform Development Progress And Provide Insights Into The Company's Industry Leading Technology Pipeline At Investor & Analyst Day

Reuters

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

QSI: Proteus will launch in 2026 with scalable, automated sequencing and broad PTM detection

Quartr

Quantum-Si Incorporated Warrant

Proteus introduces a scalable, automated protein sequencing platform with a roadmap to detect all 20 amino acids and broad PTM coverage by 2027. The system targets high-value applications, offers lower cost and higher throughput, and is set for commercial launch at the end of 2026, with early access and upgrade programs planned.

Based on Quantum-Si Incorporated [QSI] Investor Day 2025 Audio Transcript — Nov. 19 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

QSI: Proteus targets 18 amino acids at launch, full 20 by 2027, with advanced PTM profiling and automation

Quartr

Quantum-Si Incorporated Warrant

Proteus introduces a scalable, automated protein sequencing platform with superior performance, aiming for 18 amino acid detection at launch and full 20 by 2027. AI-driven recognizer development and advanced PTM detection position it for broad adoption in research, translational, and clinical markets.

Based on Quantum-Si Incorporated [QSI] Investor Day 2025 Audio Transcript — Nov. 19 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Share

FastBull

Copyright © 2025 FastBull Ltd

728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

Instagram

App Store

Google Play

Google Play

Products

Chats

Q&A with Experts

Economic Calendar

Function

Company

Feedback

Business

White Label

Data API

Web Plug-ins

Poster Maker

Affiliate Program

Risk Disclosure

The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

Not Logged In

Log in to access more features

FastBull Membership

Not yet

Purchase

Become a signal provider

Customer Service

Dark Mode

Price Up/Down Colors

Log In

Sign Up